| Title |
Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, October 2011
|
| DOI | 10.1002/14651858.cd004205.pub2 |
| Pubmed ID | |
| Authors |
Haque, Khalid N, Pammi, Mohan |
| Abstract |
Mortality and morbidity due to neonatal sepsis and necrotizing enterocolitis (NEC) is high despite the use of potent antimicrobial agents. Agents that modulate inflammation may improve outcomes. Pentoxifylline, a phosphodiesterase inhibitor, is one such agent. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| India | 1 | 2% |
| Singapore | 1 | 2% |
| Unknown | 61 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 14% |
| Student > Bachelor | 8 | 13% |
| Student > Master | 8 | 13% |
| Student > Postgraduate | 6 | 9% |
| Researcher | 5 | 8% |
| Other | 14 | 22% |
| Unknown | 14 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 50% |
| Nursing and Health Professions | 3 | 5% |
| Agricultural and Biological Sciences | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Immunology and Microbiology | 2 | 3% |
| Other | 6 | 9% |
| Unknown | 16 | 25% |